Thursday, May 7 2020
11:00 AM – 12:00 PM (EST)

In this webinar sponsored by Scintica Instrumentation, Dr. Piotr Walczak, Dr. Mirosław Janowski and Dr. Wojciech Lesniak will address this challenge and discuss why advanced imaging is essential to perform image-guided neurointerventions.

Mice are by far the most frequently used animal for modeling disease and developing therapeutic strategies including neurointerventions. However, due to its anatomical and physiological barriers, the brain is a difficult target for delivery of therapeutic agents. Systemic administration is plagued with marginal brain accumulation and high risk of off-target side effects.

In this webinar sponsored by Scintica Instrumentation, Dr. Piotr Walczak, Dr. Mirosław Janowski and Dr. Wojciech Lesniak will address this challenge and discuss why advanced imaging is essential to perform image-guided neurointerventions.

First, Dr. Janowski will provide rationale as to how imaging can be used to better understand how therapeutic agents are delivered to the brain and subsequently cleared. Next, Dr. Walczak will review methodological and technological advances for improving precision and reproducibility of brain targeting in mice based on MRI and two-photon microscopy. Finally, Dr. Lesniak will present recently-published results using ARGUS PET/CT to quantify intra-artrial delivery of antibodies, nanobodies and poly(amidoamine) dendrimers.

Key discussion topics will include:

  • Why advanced imaging is essential to perform image-guided neurointerventions
  • Why we need to visualize not only penetration of therapeutic agents to the brain but also their clearance
  • How image-guided procedures can be used to visualize and optimize delivery of therapeutic agents to the brain